MX359713B - Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. - Google Patents

Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.

Info

Publication number
MX359713B
MX359713B MX2015002816A MX2015002816A MX359713B MX 359713 B MX359713 B MX 359713B MX 2015002816 A MX2015002816 A MX 2015002816A MX 2015002816 A MX2015002816 A MX 2015002816A MX 359713 B MX359713 B MX 359713B
Authority
MX
Mexico
Prior art keywords
microspheres
wound healing
healing compositions
improved wound
compositions
Prior art date
Application number
MX2015002816A
Other languages
English (en)
Other versions
MX2015002816A (es
Inventor
Vladimir Ritter
Mery Kleyman
Deborah Hanah Bartfeld
Eilon Asculai
Original Assignee
Polyheal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyheal Ltd filed Critical Polyheal Ltd
Publication of MX2015002816A publication Critical patent/MX2015002816A/es
Publication of MX359713B publication Critical patent/MX359713B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0014—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporcionan composiciones farmacéuticas o médicas para el tratamiento de una herida, la composición comprende microesferas como un ingrediente activo y agua como un portador para dichas microesferas. En algunas modalidades, se proporcionan composiciones que comprenden un agente espesante disuelto dentro del agua para formar una solución que tiene una gravedad específica similar a la de las microesferas.
MX2015002816A 2012-09-13 2013-09-12 Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas. MX359713B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261700362P 2012-09-13 2012-09-13
PCT/IL2013/050774 WO2014041543A1 (en) 2012-09-13 2013-09-12 Improved wound healing compositions comprising microspheres

Publications (2)

Publication Number Publication Date
MX2015002816A MX2015002816A (es) 2015-05-15
MX359713B true MX359713B (es) 2018-10-08

Family

ID=50277729

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015002816A MX359713B (es) 2012-09-13 2013-09-12 Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.

Country Status (17)

Country Link
US (1) US9370533B2 (es)
EP (1) EP2895209B1 (es)
JP (1) JP6104390B2 (es)
KR (1) KR102200656B1 (es)
AU (1) AU2013316718B2 (es)
BR (1) BR112015005335B1 (es)
CA (1) CA2883455C (es)
DK (1) DK2895209T3 (es)
ES (1) ES2748805T3 (es)
HR (1) HRP20191804T1 (es)
HU (1) HUE047212T2 (es)
LT (1) LT2895209T (es)
MX (1) MX359713B (es)
PL (1) PL2895209T3 (es)
PT (1) PT2895209T (es)
RS (1) RS59410B1 (es)
WO (1) WO2014041543A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016069788A1 (en) * 2014-10-29 2016-05-06 Spectral Md, Inc. Reflective mode multi-spectral time-resolved optical imaging methods and apparatuses for tissue classification
EP3589191A4 (en) 2017-03-02 2020-11-11 Spectral MD Inc. MACHINE LEARNING SYSTEMS AND METHODS FOR MULTISPECTRAL AMPUTATION SITES ANALYSIS
US10740884B2 (en) 2018-12-14 2020-08-11 Spectral Md, Inc. System and method for high precision multi-aperture spectral imaging
US10783632B2 (en) 2018-12-14 2020-09-22 Spectral Md, Inc. Machine learning systems and method for assessment, healing prediction, and treatment of wounds
JP7261883B2 (ja) 2018-12-14 2023-04-20 スペクトラル エムディー，インコーポレイテッド 創傷の評価、治癒予測および治療のための機械学習システム
EP3899463A4 (en) 2018-12-14 2022-12-21 Spectral MD, Inc. SYSTEM AND METHOD FOR HIGH-PRECISION MULTIAPERTURE SPECTRAL IMAGING
WO2022212413A1 (en) 2021-03-30 2022-10-06 Spectral Md, Inc. System and method for high precision snapshot multi-spectral imaging based on multiplexed illumination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614310A (en) 1994-11-04 1997-03-25 Minnesota Mining And Manufacturing Company Low trauma wound dressing with improved moisture vapor permeability
US5861149A (en) 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
JP4653887B2 (ja) * 1998-10-23 2011-03-16 ポリヒール リミテッド 創傷治療用のミクロスフェアを含む組成物
CA2440803A1 (en) * 2001-03-07 2002-09-12 Pfizer Products Inc. Modulators of chemokine receptor activity
US7465463B2 (en) * 2002-09-04 2008-12-16 Polyheal, Ltd. Compositions comprising microspheres with anti-inflammatory properties for healing of ocular tissues
JP2009525975A (ja) * 2006-01-31 2009-07-16 ヴァション，デイビッド 多細胞生物の組織の治癒を促進するための組成物及びその方法
GB0607774D0 (en) * 2006-04-20 2006-05-31 Renovo Group Plc Medicaments

Also Published As

Publication number Publication date
KR20150082207A (ko) 2015-07-15
HRP20191804T1 (hr) 2019-12-27
US20150231170A1 (en) 2015-08-20
PL2895209T3 (pl) 2020-01-31
US9370533B2 (en) 2016-06-21
RS59410B1 (sr) 2019-11-29
JP2015528492A (ja) 2015-09-28
PT2895209T (pt) 2019-10-28
HK1212638A1 (en) 2016-06-17
BR112015005335A2 (pt) 2017-07-04
AU2013316718A1 (en) 2015-03-12
DK2895209T3 (da) 2019-10-21
HUE047212T2 (hu) 2020-04-28
CA2883455C (en) 2020-01-28
AU2013316718B2 (en) 2016-09-29
WO2014041543A1 (en) 2014-03-20
LT2895209T (lt) 2019-10-25
KR102200656B1 (ko) 2021-01-11
EP2895209A4 (en) 2016-04-20
JP6104390B2 (ja) 2017-03-29
ES2748805T3 (es) 2020-03-18
EP2895209B1 (en) 2019-07-17
CA2883455A1 (en) 2014-03-20
EP2895209A1 (en) 2015-07-22
BR112015005335A8 (pt) 2018-01-30
BR112015005335B1 (pt) 2020-03-10
MX2015002816A (es) 2015-05-15

Similar Documents

Publication Publication Date Title
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX365939B (es) Moduladores del transporte nuclear y usos de los mismos.
NZ702663A (en) Nuclear transport modulators and uses thereof
MX2016016666A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2016015093A (es) Derivados de acido boronico y sus usos terapeuticos.
PH12015500561A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
PH12015500115A1 (en) Glucagon analogues
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
MX2013004061A (es) Analogos de ciclosporina.
UA115357C2 (uk) Похідні піридин-4-ілу
PH12012500773A1 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2013004062A (es) Analogos de ciclosporina.
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
EP2870964A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF COLITIET COMPRISING S-ALLYL-L-CYSTEINE AS ACTIVE INGREDIENT AND MEDICAL PREPARATION COMPRISING THE SAME
MX2014011218A (es) Uso de agentes tensoactivos anfotericos para la prevencion y tratamiento de biopeliculas vaginales patogenas en infecciones vaginales.
WO2014031982A3 (en) Methods and compositions for treating pain
MX2016014261A (es) Uso de acido 1,3-propandisulfonico o sales farmaceuticamente aceptables del mismo para el tratamiento de sarcoidosis.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
GB2519004A (en) Quinone compounds and their uses for the treatment of cancer
NZ764041A (en) Use of 1,3-propanedisulfonic acid or pharmaceutically acceptable salts thereof for the treatment of sarcoidosis
TR201203083A2 (tr) Sefdinir ve klavulanik asit içeren farmasötik dozaj formu.
TR201203085A2 (tr) Sefetamet ve klavulanik asit içeren bileşimler.
TR201203084A2 (tr) Sefditoren pivoksil ve klavulanik asit içeren formülasyonlar.

Legal Events

Date Code Title Description
FG Grant or registration